Interview with Jan-Willem Eleveld, Vice President, Counsulting & Services,…
You spent most of your career in the pharmaceutical industry with Bristol Meyers Squibb and earlier on for NV Organon which you joined in 1998. In 2007 you left to…
Address: 302, Level 3, Damansara Uptown 2, 2 Jalan SS21/37, 47400 Petaling Jaya, Selangor,Malaysia
Tel: 603 7710 7380
Web: http://www.imshealth.com/portal/site/ims
IMS Health is the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries. We offer a variety of solutions to help clients understand the marketplace, improve marketing effectiveness and optimize sales productivity. With a presence in more than 100 countries and over 55 years of experience, IMS applies leading-edge technologies to transform billions of pharmaceutical transactions collected from thousands of sources into strategic insights. Interpreted and analyzed by IMS experts, these insights are an unmatched source of trends and perspectives about the pharmaceutical marketplace – precise market intelligence that can be translated into action.
Commercial Implementation Services: We help meet the challenges of commercial information management, with cutting-edge solutions in reporting and analytics, and operations and compensation outsourcing.
Managed Markets Services: With more than three-quarters of U.S. prescriptions underwritten by third-party payers, we’re the ones to call to help meet contracting, compliance and systems challenges.
Market Research Services: We not only deliver views of market position, but also provide related services — including outsourcing of key market research processes.
We apply Evidence-Based ConsultingSM that can have an immediate impact on the business and market performance of our clients. We help to strengthen portfolios, optimize product launches, mount superior marketing efforts, forge more productive alliances and optimize sales force structure and deployment.
Product & Portfolio Strategy
Companies that don’t plan for the future don’t have one. We help keep the compass pointed in the right direction.
Commercial Effectiveness
A surprisingly low percentage of pharmaceutical brands outperform expectations. We help clients gain access to that elite club.
Pricing & Market Access
There’s both an art and a science to launching new products and ensuring optimal market access and price. We understand the complex dynamics shaping the prospects for products in research and development as well as for those already in-market.
You spent most of your career in the pharmaceutical industry with Bristol Meyers Squibb and earlier on for NV Organon which you joined in 1998. In 2007 you left to…
Cliford Patrick, regional vice president listings at MIMS expands on the opportunities that data can bring to healthcare in Malaysia, from improving patient safety, to streamlining the healthcare budget. Patrick…
Saravanan G., group managing director of Biocare Group, details the opportunities he identified to create the first MDI (Metered Dose Inhalers) manufacturing plant in Malaysia. He also explains further the…
Siobhan Das, executive director of the American Malaysian Chamber of Commerce, discusses the close business ties between the two countries and the future opportunities that exist for further investment growth…
Ch’ng Kien Peng, executive director of Xepa-Soul Pattinson, offers insights on the dynamic healthcare industry in Malaysia and the new government’s key role in supporting the local industry. He also…
Indranil Sen, managing director of Ranbaxy Malaysia, a Sun Pharma company, discusses the role of generics in the Malaysian pharmaceutical sector, and their strategy to lead the market, rather than…
Javed Ghulam, CEO of AJ Research & Pharma, offers insights into the dynamic pharma industry in Malaysia and what it takes to be a competitive player in the region. …
Billy Urudra, president of the Malaysian Organisation of Pharmaceutical Industries, highlights the major trends and challenges in the Malaysian pharmaceutical industry, especially for generics players and touches upon the potential…
Lance Duan, general manager of Roche Malaysia, discusses the dynamic changes in the country’s health system and the possibilities that exist for Roche to establish a collaborative relationship with the…
Dr. Saunthari Somasundaram walks us through the NCSM’s mission to raise awareness on cancer prevention and early diagnosis in Malaysia. She details the need for more government support to make…
Jamaludin Elis, country CEO of Chulia Life Sciences Sdn Bhd, discusses the diverse activities of Chulia Group’s various subsidiaries, as well as the group’s upcoming projects in the healthcare industry.…
Following the death penalty handed to Muhammad Lukman, a 29-year old man who was convicted of possessing, processing and distributing medicinal cannabis oil, public outcry has caused Malaysian officials to reconsider the punishment. Muhammad…
Roberto Benetello, CEO of the EU-Malaysia Chamber of Commerce and Industry (EUMCCI), discusses the chamber’s function in Malaysia, the current business environment of the country, and the upcoming changes that…
See our Cookie Privacy Policy Here
